Filing Details

Accession Number:
0000899243-21-011235
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-11 20:40:54
Reporting Period:
2021-03-09
Accepted Time:
2021-03-11 20:40:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1537917 Tyme Technologies Inc. TYME Pharmaceutical Preparations (2834) 453864597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711342 Steve Hoffman C/O Tyme Technologies, Inc.
1 Pluckemin Way, Suite 103
Bedminster NJ 07921
Chief Science Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-09 41,750 $1.92 24,614,998 No 4 S Direct
Common Stock Disposition 2021-03-10 41,750 $1.98 24,573,248 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.85 to $2.03, inclusive, on March 9, 2021, and prices ranging from $1.86 to $2.125, inclusive, on March 10, 2021. The reporting person undertakes to provide to Tyme Technologies, Inc., any security holder of Tyme Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.